1. Home
  2. LEGN vs CHH Comparison

LEGN vs CHH Comparison

Compare LEGN & CHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

N/A

Current Price

$17.42

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Logo Choice Hotels International Inc.

CHH

Choice Hotels International Inc.

N/A

Current Price

$118.65

Market Cap

4.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
LEGN
CHH
Founded
2014
1939
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.7B
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
LEGN
CHH
Price
$17.42
$118.65
Analyst Decision
Buy
Hold
Analyst Count
13
18
Target Price
$42.46
★ $117.18
AVG Volume (30 Days)
★ 2.3M
549.4K
Earning Date
11-10-2026
11-02-2026
Dividend Yield
N/A
★ 0.97%
EPS Growth
N/A
★ 27.42
EPS
N/A
★ 3.12
Revenue
N/A
★ $1,596,793,000.00
Revenue This Year
$38.71
$2.74
Revenue Next Year
$18.83
$3.68
P/E Ratio
★ N/A
$37.96
Revenue Growth
N/A
★ 0.75
52 Week Low
$16.24
$84.04
52 Week High
$37.50
$123.82

Technical Indicators

Market Signals
Indicator
LEGN
CHH
Relative Strength Index (RSI) 37.79 63.55
Support Level $17.43 $104.17
Resistance Level $19.92 $122.88
Average True Range (ATR) 1.50 3.61
MACD -0.47 0.08
Stochastic Oscillator 1.15 78.06

Price Performance

Historical Comparison
LEGN
CHH

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About CHH Choice Hotels International Inc.

At year-end 2025, Choice Hotels operated 657,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total rooms), while Ascend and Cambria (10%) are lifestyle and select-service brands, and WoodSpring (5%) is the company's largest extended-stay brand. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represented 78% of total rooms in 2025.

Share on Social Networks: